Mineralocorticoid receptor antagonists for heart failure: systematic review and meta-analysis

BACKGROUND: Mineralocorticoid receptor antagonists (MRAs) have been associated with improved patient outcomes in patients with heart failure with reduced ejection fraction (HFrEF) but not preserved ejection fraction (HFpEF). We conducted a systematic review and meta-analysis of selective and nonsele...

Descripción completa

Detalles Bibliográficos
Autores principales: Berbenetz, Nicolas M., Mrkobrada, Marko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5134129/
https://www.ncbi.nlm.nih.gov/pubmed/27905877
http://dx.doi.org/10.1186/s12872-016-0425-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5134129/
https://www.ncbi.nlm.nih.gov/pubmed/27905877
http://dx.doi.org/10.1186/s12872-016-0425-x

Ejemplares similares